References
- Criscuolo GR. Clinical neurosciences in the decade of the brain hypotheses in neuro-oncology: The genesis of peritumoural vasogenic brain edema and tumour cysts: A hypothetical role for tumour-derived vascular permeability factor. Yale J Biol Med 1993; 66: 227–314
- Lohle PNM, Verhagen ITHJ, Teelken AW. The pathogenesis of cerebral gliomatous cysts. Neurosurgery 1992; 30: 180–185
- Boethius J, Lefvert AK, Siden A Evidence for a local immune activation in cystic brain tumours. J Neurosurg 1990; 73: 933–935
- Gustin T, Bachelot T, Verna J-MG. Immunodetection of endogenous opioid peptides in human brain tumours and associated cyst fluids. Cancer Res 1993; 53: 4715–4719
- Kikuchi K, Edward A, Nauuwelt A. Presence of immunosuppres-sive factors in brain-tumour cyst fluid. J Neurosurg 1983; 59: 790–799
- Szymas J, Morkowski S, Tokarz F. Determination of the glial fibrillary acidic protein in human cerebrospinal fluid and in cyst fluid of brain tumours. Acta Neurochir 1986; 83: 144–150
- Westphal M, Nausch H, Herrmann H-D. Cyst fluids of malignanthuman brain tumours contain substances that stimulate the growth of cultured human gliomas of various histological type. Neurosurgery 1989; 25: 196–201
- Persson L, Boethius J, Gronowitz JS. Thymidine kinase in brain-tumour cyst. J Neurosurg 1985; 63: 568–572
- Alger JR, Frank JA, Bizzi A. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglu-cose PET. Radiology 1990; 177: 633–641
- Bruhn H, Frahm J, Gyngell ML. Noninvasive differentiation of tumours with use of localized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral tumours. Radiology 1989; 172: 541–548
- Go KG, Keuter E, Kamman RL. Contribution of magnetic resonance spectroscopic imaging and L-[1C] tyrosine positron emission tomography to localization of cerebral gliomas for biopsy. Neurosurgery 1994; 34: 994–1002
- Go KG, Kamman RL, Mooyaart EL. Localised proton spectro-scopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography. Neuroradiology 1995; 37: 198–206
- Hubesch B, Sappey-Marinier D, Roth K. P-31 MR spectroscopy of normal human brain and brain tumours. Radiology 1990; 174: 401–409
- Kugel H, Heindel W, Ernestus R-I. Human brain tumours: Spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992; 183: 701–709
- Luyten PR, Marien AJH, Heindel W. Metabolic imaging of patients with intracrainial tumours: H-1 MR spectroscopic imaging and PET. Radiology 1990; 176: 791–799
- Murray KJ, Ausmann JI, Chou SN. Immunoproteins in human brain tumour cyst fluids. J Neurosurg 1977; 46: 314–319
- van Vaals ii, Bergman AH, van den Boogert Hi. Noninvasive in vivo localized H spectroscopy of human astrocytoma implanted in rat brain: Regional differences followed in time. NMR Biomed 1991; 4: 125–132
- Go KG, Hew JM, Kamman RL. Cystic lesions of the brain. A classification based on the pathogenesis, with consideration of histological and radiological features. Eur J Radiol 1993; 17: 69–84
- Warburg O. On the origin of cancer cells. Science 1956,123: 309–314
- Warburg O. Versuche an iiberlebendem Karzinomgewebe. Biochem Z 1923; 142: 302–307
- Kugel H, Heindel W, Ernestus R-I. Image-guided localized H NMR spectroscopy: A noninvasive tool for differentiation of human brain tumours. Soc Magn Res Med 1991; 10: 317–333
- Di Chiro G. Positron emission tomography using [18F] fluoro-deoxyglucose in brain tumours. Invest Radiol 1987; 22: 360–371
- Heesters MAM, Kamman RL, Mooyaart EL. Localised proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J Neurooncol 1993; 17: 27–35
- Mangiardi JR, Yodice P. Metabolism of the malignant astro-cytoma. Neuosurgery 1990; 26: 1–19 [review article]
- Luyten PR, Marien AJH, Heindel W. Metabolic imaging of patients with intracranial tumours: H-1 MR spectroscopic imaging and PET. Radiology 1990; 176: 791–799